CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells
Boonyakorn Boonsri, Kiren Yacqub-Usman, Pakpoom Thintharua, Kyaw Zwar Myint, Thannicha Sae-Lao, Pam Collier, Chinnawut Suriyonplengsaeng, Noppadol Larbcharoensub, Brinda Balasubramanian, Simran Venkatraman, Isioma U. Egbuniwe, Dhanwant Gomez, Abhik Mukherjee, Supeecha Kumkate, Tavan Janvilisri, Abed M Zaitoun, Thiti Kuakpaetoon, Rutaiwan Tohtong, Anna M Grabowska, David O. Bates, Kanokpan Wongprasert
Cancer Research and Treatment. 2021;53(2):457-470.   Published online 2020 October 7    DOI: https://doi.org/10.4143/crt.2020.585

Excel Download

Design and Synthesis of Quinazolinone Tagged Acridones as Cytotoxic Agents and Their Effects on EGFR Tyrosine Kinase
Archiv der Pharmazie. 2014;347(9):624-634   Crossref logo
Link1 Link2

EGFRC797S mutation and fourth-generation EGFR tyrosine kinase inhibitors
Protein Kinase Inhibitors. 2022;689-709   Crossref logo
Link1 Link2

Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells
Cancer Research and Treatment. 2021;53(2):457-470   Crossref logo
Link1 Link2 Link3

Drug Tolerance to EGFR Tyrosine Kinase Inhibitors in Lung Cancers with EGFR Mutations
Cells. 2021;10(7):1590   Crossref logo
Link1

Bruton’s Tyrosine Kinase Inhibitors: A New Generation of Promising Agents for Multiple Sclerosis Therapy
Cells. 2021;10(10):2560   Crossref logo
Link1

Bruton's Tyrosine Kinase (BTK) Inhibitors as Sensitizing Agents for Cancer Chemotherapy
Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy. 2019;109-124   Crossref logo
Link1 Link2

Kinase-Inactivated EGFR Is Required for the Survival of Wild-Type EGFR-Expressing Cancer Cells Treated with Tyrosine Kinase Inhibitors
International Journal of Molecular Sciences. 2019;20(10):2515   Crossref logo
Link1

ALK Tyrosine Kinase Inhibitors in Drug Sensitization
Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy. 2019;45-52   Crossref logo
Link1 Link2

Microrna-144 Expression Overcomes Resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR Mutant Lung Cancer Cells by Targeting Survivin
Chest. 2016;150(4):714A   Crossref logo
Link1 Link2

Effect of siRNAs targeting the EGFR T790M mutation in a non-small cell lung cancer cell line resistant to EGFR tyrosine kinase inhibitors and combination with various agents
Biochemical and Biophysical Research Communications. 2013;431(3):623-629   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.